Dose-response relationship of DNA and recombinant Fowlpox virus prime-boost HIV vaccines - Implications for future trials
Robert De Rose, Mark T Sullivan, C Jane Dale, Anthony D Kelleher, Sean Emery, David A Cooper, Ian A Ramshaw, David B Boyle, Stephen J Kent
HUMAN VACCINES | LANDES BIOSCIENCE | Published : 2006
Estimating effective doses of novel HIV vaccines is challenging. Dose-response analyses of DNA and fowlpox virus HIV vaccines showed that 1 mg of DNA vaccine and 5 x 10(7)pfu of fowlpox virus booster was immunogenic in macaques. However, this dose was poorly immunogenic in humans. When adjusted for body surface area, the human dose studied was equivalent to a poorly immunogenic lower dose in monkeys. These data provide a rationale for guiding dosing in future trials of HIV vaccine technologies.
Awarded by NIAID NIH HHS